The officer's consistent selling over two weeks is notable but not alarming given the modest size relative to market cap (~0.035% of shares outstanding). Monitor for any acceleration of insider sales or a Form 4 filing confirming execution. No immediate trading catalyst.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 29 $55.67entry
- T+1 · 6mo ago −4.54%α −4.80% · $53.14
- T+5 · 6mo ago −9.52%α −7.00% · $50.37
- T+20 · 5mo ago +18.50%α +20.30% · $65.97
- T+60 · 3mo ago +4.98%α +3.79% · $58.44
Price Chart
How similar events traded
Executive Summary
Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 on May 28, 2026, indicating intent to sell 10,264 shares of common stock valued at approximately $594,671. The proposed sale follows a series of recent open-market sales totaling 75,467 shares for about $4.3 million between May 15 and May 27, 2026, and is tied to a stock option exercise. While the filing signals insider intent to monetize equity, the officer has been a consistent seller over the past two weeks, which may raise mild concern but is not unusual for routine option exercises and diversification.
Key Facts
- Officer Dennis Mulroy filed Form 144 on May 28, 2026, to sell 10,264 shares of common stock.
- The proposed sale has an approximate market value of $594,671 based on a $57.93 per share price.
- The shares to be sold are from a stock option exercise executed on May 28, 2026.
- Mulroy has sold 75,467 shares in seven separate transactions between May 15 and May 27, 2026, totaling approximately $4.3 million.
- The filing is an advance notice of intent to sell; the actual sale may not occur.
- AnaptysBio has a market cap of $1.7 billion and analyst consensus is 89% bullish (16 Buy, 2 Hold).
Financial Impact
Proposed sale of 10,264 shares valued at ~$594,671; cumulative recent sales of 75,467 shares for ~$4.3 million.
Risk Factors
- Insider selling may signal lack of confidence if it accelerates or becomes material relative to holdings.
- Form 144 is only an intent to sell; the sale may not be executed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005251 |
| Document: 0001950047-26-005251-index.html | 0001950047-26-005251 |
| Document: 0001950047-26-005251.txt | 0001950047-26-005251 |
Track record
28 reports on ANAB
10 of 19 bullish or bearish reports moved the stock their way by T+1. Best: +41.26% at T+60 after the Mar 3, 2026 report. 13 of 19 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $46.25 Now $45.73 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 4/10 Entry $46.25 to $45.73 Now $45.73 +1.12% ▲ +1.12% −0.79% vs SPY
- Nov 6, 202610d ago Institutional Cluster Neutral 2/10 Entry $46.45 to $47.97 Now $45.73 −1.55% ▲ +3.27% +0.91% vs SPY
- Sep 21, 20268w ago Press Release Neutral 5/10 Entry $53.92 to $50.77 Now $45.73 −15.19% ▼ −5.84% −5.12% vs SPY
- Aug 12, 202613w ago Institutional Cluster Bullish 5/10 Entry $56.02 to $58.47 Now $45.73 −18.37% ▲ +4.37% +4.57% vs SPY
- Jun 29, 202620w ago 144 Bearish 6/10 Entry $67.50 to $65.43 Now $45.73 +32.25% ▲ +3.07% +2.93% vs SPY
- Jun 29, 202620w ago DEFA14A Neutral 2/10 Entry $67.50 to $65.43 Now $45.73 −32.25% ▼ −3.07% −2.93% vs SPY
- Jun 26, 202620w ago 144 Bearish 6/10 Entry $65.97 to $67.50 Now $45.73 +30.68% ▼ −2.32% −1.54% vs SPY
- Jun 22, 202621w ago 8-K Neutral 2/10 Entry $59.43 to $58.48 Now $45.73 −23.05% ▼ −1.60% −1.55% vs SPY
- Jun 17, 202621w ago 144 Bearish 5/10 Entry $57.51 to $59.99 Now $45.73 +20.48% ▼ −4.31% −4.63% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers